Figure 3From: Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifenHMG-CoAR protein expression in Cohort II. (a) Immunohistochemical analysis of 3-hydroxy-3-methylglutharyl-coenzyme A reductase (HMG-CoAR) demonstrating different levels of staining intensity. (b) Kaplan-Meier estimates of recurrence-free survival according to HMG-CoAR expression in three groups. (c) Kaplan-Meier estimates of recurrence-free survival according to HMG-CoAR expression (negative = 0 or positive = 1 to 3) in all patients (n = 422).Back to article page